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Introduction
To aid the early detection of cancer which may help in fighting the 
disease, the discovery of biomarkers is required. Analysis of volatile 
organic compounds (VOCs) as potential biomarkers of cancer appears 
to be a very promising approach as it is fast, non-invasive and the cost 
of sample collection and assay is potentially low. It is thought that the 
presence of a tumour generates new VOCs, normally not produced 
by the healthy body, and/or alters the levels of VOCs detected in the 
body during normal physiological processes. Canine scent detection 
can distinguish between the various biological samples coming from 
patients with and without cancer, often with high sensitivity and 
specificity [1]. Different VOC profiles have been associated with various 
diseases such as cancer, genetic and metabolic disorders, schizophrenia 
or infectious diseases [2]. Furthermore, different patterns of VOCs 
detected in the headspace [HS] of numerous cancerous and non-
cancerous cells grown in vitro suggest that potential cancer-specific 
biomarkers exist [3-5]. The candidate volatile biomarkers, as well as the 
pros and cons of different biological matrices available for researchers 
in the quest for the VOC biomarkers of cancer, have been reviewed in 
ref. [5-10]. 
The concentrations of the majority of the VOCs occurring in 
biological samples are relatively low: in the ppm-ppt range in human 
breath, blood and urine [10-14]. What is more, VOCs are extracted 
from complex mixtures, therefore before the analysis there is a need 
for a pre-concentration step to enrich the analytes of interest to a 
detectable level, as required by the analytical technique to be used. 
However, pre-concentration itself requires multiple steps, so it is a 
significant source of errors, resulting in a decrease in the reliability 
and accuracy of the assay [15]. A decrease in the number of steps of 
the pre-concentration technique results in better reproducibility 
and the elimination of interfering compounds. The properties of an 
ideal device for a sample pre-concentration include simplicity of use, 
high extraction capacity, high selectivity, speed, efficiency, possible 
automation and miniaturisation, consideration of the safety of both the 
environment and the user, and finally compatibility with alternative 
techniques for separation and detection [16,17]. When compared to 
the traditional extraction techniques of liquid-liquid extraction and 
solid-phase extraction, microextraction techniques exhibit some of 
these properties very well. 
Solid phase microextraction (SPME), invented by Pawliszyn and 
Arthur in 1989 [18], in particular has become very popular in the field 
of VOC detection in various matrices and various industries due to the 
simplicity of the SPME device, automation of the process, the absence of 
a need for solvents, and its compatibility with both gas chromatography 
(GC) and liquid chromatography (LC) [19]. SPME, next to purge and 
trap [PT] employing sorbent tubes (followed by thermal desorption), is 
the main extraction technique used to date for the collection of VOCs 
in both in vivo and in vitro studies of potential biomarkers of cancer. 
SPME has been used in many studies as a technique of extraction of 
VOCs from such human specimens as breath, urine and blood but also 
from the HS of the cancer cells in vitro in lung, breast, colon, gastric, 
skin and renal cancers [20-28]. A review discussing the use of HS-SMPE 
with GC separation for the extraction of VOCs from bio-fluids and 
bio-materials has been published by Mills and Walker [29]. Reviews 
looking at the recent advances in SPME techniques for bioanalytical 
studies have been published [30,31]. Finally, the theory of SPME has 
been described previously in ref. [32-36]. 
This review firstly describes briefly the principles of SPME 
as an extraction technique. Next it gives a tutorial on the steps in 
SPME method development, whilst also discussing the particular 
parameters used by the researchers in studies of cancer-associated 
potential biomarkers. Finally, it briefly examines alternative extraction 
techniques.
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Abstract
The analysis of volatile organic compounds [VOCs] is an attractive approach to the discovery of potential 
cancer biomarkers due to its non-invasive nature and potential low costs of sampling and analysis. Solid phase 
microextraction [SPME] is one of the main extraction techniques used to date for the collection of VOCs from 
both in vivo and in vitro samples in studies of potential biomarkers of various types of cancer. It offers simplicity of 
use, compatibility with both gas-chromatography [GC] and liquid-chromatography [LC] separation techniques and 
relatively lower costs. Development of the SPME method includes several important considerations: selection of the 
sampling mode, type of fiber and holder, optimisation of incubation, extraction and desorption conditions, and finally 
the use of an appropriate calibration procedure. This review summarizes and discusses the particular parameters of 
the SPME method development used by researchers to date for VOCs collection, from various biological matrices, 
in search of potential biomarkers of cancer.
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Principles of SPME Sampling
The SPME technique consists of three steps. Firstly, the sample is 
placed in the sampling vial (in the case of liquid or solid samples some 
gas volume is left above it) and the vial is tightly closed. Here the sample 
is incubated for a specific period of time at a certain temperature. During 
the second step, the analytes are adsorbed and/or absorbed onto the 
fiber. The vial is equilibrated at a constant temperature for the time of 
extraction. The third step is a desorption of VOCs from the SPME fiber 
in a hot injector port of a gas chromatograph (Figure 1). In the case of 
high performance liquid chromatography [HPLC] the SPME fiber is 
introduced into the desorption chamber of HPLC-SPME interface. The 
interface is a six port injector valve which has a desorption chamber 
instead of a sample loop. The VOCs are desorbed from the fiber into 
the mobile phase in a result of either dynamic or static desorption. In 
dynamic desorption the analytes are desorbed in the moving stream of 
mobile phase. In static desorption the fiber is soaked in mobile phase 
for a specific period of time before the compounds are injected onto 
the column [37].
SPME is a non-exhaustive equilibrium extraction technique, as 
only a small portion of the target compound is removed from the 
sample. During extraction, sample molecules preferentially partition 
between the matrix, headspace and the stationary phase (in the case 
of a liquid or solid sample), or between the sample and the stationary 
phase (gas samples) as a result of absorption and/or adsorption 
process (this depends on the coating type) [34] (Figure 2). With long 
enough extraction times, an equilibrium concentration of the analyte 
is established between the two or three phases. When equilibrium is 
reached, the exposure of the fiber for a longer period of time does not 
collect any more analyte [32]. The period after which equilibrium is 
reached depends on the type of the analytes and extraction conditions, 
and takes from a few minutes to few hours [29]. The partitioning 
between the three phases (or two in the case of gas samples) depends 
on the affinity of the analyte to each of them at equilibrium. After the 
defined period of extraction the fiber is moved to a GC injector or a 
HPLC chamber interface. SPME also may be used for pre-equilibrium 
analyte collection.
Because there are two types of SPME coatings [adorptive (solid) 
and absorptive (liquid)], the behaviour of the compounds analysed 
differs (Figure 3). In the process of adsorption, the extraction of the 
compounds occurs only on the surface of the coating. The analytes 
are physically traped or retained by the stationary phase via chemical 
reactions. The total surface area which is available for adsorption is 
proportional to the volume of the coating if a constant porosity of the 
stationary phase is assumed. The amount of analyte adsorbed depends 
on the initial concentration of the analyte as well as on the concentration 
of the competitive analyte (competitive displacement reactions). 
During the absorption process the analytes partition preferentially at 
equilibrium in the porous material of the liquid polymeric phase. The 
absorption process also depends on the initial concentration of the 
analyte in the sample. Again, displacement processes may take place 
during the absorption, but some studies in water analysis indicate that 
this is a minor concern in these types of SPME coating [38]. 
SPME Method Development
Development of the SPME method includes several important 
considerations: selection of the sampling mode, type of fiber and holder, 
optimisation of incubation (equilibration), extraction and desorption 
conditions, and finally the employment of an appropriate calibration 
procedure [34]. Any given parameter of extraction and desorption 
must be established experimentally for a given sample and application. 
These experiments involve the analysis of a series of identical mixtures 
(samples or prepared mixtures with known amounts of added 
analytes). The conditions of the extraction and desorption are identical 
except for the one parameter that is varied. At the end of the series of 
analyses a plot of the analyte response versus a tested parameter is built 
and the point where there is no longer an improvement, or there is a 
lower response, is established. The analysis of the VOCs as potential 
biomarkers of cancer is usually a profiling of the whole sample and all 
the analytes present in the sample are of potential interest. Therefore, 
researchers also compare a tested parameter with the number of 
analytes detected. A compromise between the various responses for 
different analytes and the number of analytes detected is reached and 
this value is used for further studies. 
An interesting experimental approach towards SPME method 
development was applied by Monteiro et al. [22]. They used a central 
composite design (CCD), a multivariate statistical model, to optimise 
the extraction conditions of VOCs from the urine of the patients 
with renal cancer. Instead of performing the evaluation of each of the 
extraction variables (time of incubation, extraction temperature and 
Figure 1: Diagram of analysis with solid phase microextaction-gas chromatography-mass spectrometry [SPME-GC-MS] [5].
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time, salt addition) independently, the combinations among them 
were defined and employed. CCD enabled for the evaluation of the 
significance of each of the factors as well as the relationships between 
them. The number of experiments, time and cost was reduced.
SPME Device
The SPME device is composed of the holder and in it, the fiber unit. 
There are two variants of the SPME holder: one for manual use and 
one for use with autosamplers or with an HPLC-SPME interface. The 
fiber assembly consists of a fiber core which is attached via a hub to a 
stainless steel guiding rod. The guiding rod is enclosed in a hollowed 
needle that pierces the septum of the vial. During extraction, the fiber 
is pushed out from this needle and when not in use retracted back. The 
fiber core is coated with stationary phase (1 or 2 cm long) and made of 
fused silica (which is relatively easy to break), StableFlex (consisting 
of 80 µm fused silica with 20 µm plastic polymer, which reduces the 
chances of breaking the needle but has a thermal limitation of 320 ºC), 
or metal alloy (no thermal limitations; only to use with MicrosealTM 
septumless systems) [34]. The fiber assemblies for manual use have 
24-gauge needles with an outer diameter of 565 µm, which is the 
smallest possible size that will still retract the 100 µm thick stationary 
phase. The smallest possible diameters are required for minimal septa 
coring to prevent losing the sample. However, the 24-gauge needles are 
very easy to snap while using an autosampler. For these purposes there 
are more durable 23-gauge needles available with an outside diameter 
of 646 µm [34]. On the other hand, 23-gauge needles are recommended 
for use only with septumless systems. Fiber assemblies are used with 
sample vials with caps containing thin silicone septa, which seal tightly 
around the needle during piercing. 
The profiling of VOCs in the investigation of cancer biomarkers is 
dominated by the use of manual SPME. In breath analysis, the reasons 
for the use of manual SPME are the sample size (e.g. 5L or 1L Tedlar 
bag) and the need for samples of room air to be taken as a control 
reference. However, there does not seem to be any obvious explanation 
for its use while working on other matrices, other than the higher cost 
of an autosampler. Seven studies to date employing an autosampler 
were conducted on breath and urine matrices (Table 1). The use of 
an autosampler enables the testing of a larger number of samples 
(ninety eight 2 mL vials per tray or thirty two 10/20 mL vials per tray), 
controlled heating and agitation of a sample during incubation and 
extraction, pre-conditioning of the SPME fiber before each run after 
desorption, control of the sampling and injection depth of the fiber and 
finally the opportunity to build the method by employing sequential 
methods. All of them aid better accuracy and precision [34].
SPME Sampling Mode
There are three SPME extraction modes: DI (direct immersion) 
and HS, in which the fiber is introduced directly into the sample and 
into the air above the sample, respectively; and a membrane protected 
mode for dirty samples. The analysis of VOCs is performed either by 
DI for the gaseous matrix, or HS, which is the most efficient mode 
for the extraction of analytes from complex liquids and solid samples 
(with high molecular weight interferences such as proteins) and for the 
collection of volatile compounds in general [34].
SPME Fiber Type
There are four polymers commercially used as SPME stationary 
phases: divinylbenzene (DVB), polydimethylsiloxane (PDMS), 
polyacrylate (PA) and carbowax-polyethylene glycol (PEG). They 
are used on their own (and are available in different thicknesses of a 
coating) or in combination mixed with carboxen (CAR). The stationary 
phases differ by polarity (polar, bipolar, non-polar) and extraction 
mechanism (absorbent or adsorbent). The polarity of the compounds 
of interest and their molecular weight are factors for choosing of the 
fiber coating (Table 2). 
Absorbent-type Coatings
The absorbent is a polymer with liquid properties bonded in various 
thicknesses to the fiber core. In this type of coating, analytes travel in 
and out of the stationary phase, which they are attracted to on the basis 
of their polarity (Figure 3). Retention depends mainly on the thickness 
of the stationary phase. Larger analyte molecules are retained longer by 
the coating as they travel through it less quickly than smaller molecules. 
Coating with thicker phase causes a longer retention of smaller 
molecules, therefore the choice of the thickness depends on the size 
of the molecules analysed [34]. There are three commercially available 
absorbent-type stationary phases: non-polar PDMS, moderately polar 
PA and polar PEG.
Figure 2: Principles of extraction by headspace-solid phase microextraction 
[HS-SPME].
Figure 3: Extraction mechanisms for absorptive (liquid) and adsorptive (solid) 
fiber coatings.
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Reference Analysed matrix
Fiber, type of holder,
fibers tested
Extraction procedure 
details Analytical  technique
LOD (and 
scan mode)
RSD
[%] R
2 Scan range
[m/z]
Abaffy et al.
[39]1
[40]2
tissue 
F: PDMS/DVB 
H: manual
R1: unknown complex matrix: 
non-polar fiber with broad 
selectivity
T1: 75 μm PDMS/CAR
S: 3 mm punch skin biopsy in 
1.5 ml vial with 0.3 ml inner 
tube
E: RT (60 min)
D1: ns
D2: 220 ºC (1 min)
GC-QMS/EI
DB-5MS column (25 m x 0.2 
mm x 0.33 μm)
ns ns
1
8.62 ns 30-300 
Barash et al.
[41]1
[42]2
cell culture 
medium
F: DVB/CAR/PDMS
H: manual
S: ultra II SKC badge (with 
the collected HS emitted from 
the cells in vitro) placed in 
a thermal desorption device 
(volume 350 ml or 750 ml)
E: 270 ºC (time ns1, 30 min2)
D: 270 ºC (time ns)
GC-QMS/EI
H5-5MS column (30 m x 
0.25 mm x 0.25 μm)
ns ns ns ns
Buszewski 
et al.
[43]
tissue F: 75 μm CAR/PDMS H: manual
S: approx. 2 g of tissue in 20 
ml vial
I: 40 ºC (10 min)
E: 40 ºC (15 min)
D: 200 ºC (1 min)
GC-QMS/EI
CPQ column (25 m x 0.25 
mm x 3 μm)
0.6-2.8 ppb 
FS 6-10
0.996-
0.999 15-220 
Buszewski 
et al.
[44]
breath, 
tissue
F: 75 μm CAR/PDMS 
H: manual
S: 500 ml [breath]
S: size ns [tissue]
E: 25 ºC (10 min) [breath]
E: 25 ºC (30 min) [tissue]
D: 200 ºC (time ns)
GC-QMS/EI
CPQ column (25 m x 0.25 
mm x 3 μm)
ns ns ns 15-220 
Chen et al.
[45]
breath, 
cell culture 
medium
F: 100 μm PDMS 
H: manual
R: VOCs in human breath are 
non-polar
S: 5L (Tedlar bag) [breath]
S: 30 mL in 100 mL glass 
bottle [cell culture medium] 
E: 40 ºC (time ns) [breath]
E: 37 ºC (40 min, 1100 rpm) 
[cell culture medium]
D: 260 ºC (10 min)
GC-FID
DB-1 column (30 m x 0.25 
mm x 0.25 μm)
ns  ns ns n/a
D’Amico 
et al.
[46]
gauze 
pads that 
wiped 
the skin 
surface
F: DVB/CAR/PDMS
H: ns
S: gauze pad in 20 ml glass 
vial
E: RT (15 h)
D: 250 ºC (3 min)
GC-QMS/EI
EQUITY-5 column (30 m x 
0.25 mm x 0.25 μm) 
ns ns ns 50 - 550
Deng et al.
[47] blood
F: 75 μm CAR/PDMS 
H: manual
T: 100 μm PDMS, PDMS/
DVB, 65 μm CW/DVB, PA
S: 5 ml in 15 ml glass vial
E: 60 ºC (15 min, 1100 rpm) 
D: 250 ºC (30 s)
GC-QMS/EI
HP-5MS column (30 m x 
0.25 mm x 0.25 μm
0.026 nM
(hexanal)
0.032 nM
(heptanal)
SIM
4.2 
hexanal)
3.6 
(heptanal)
0.99 ns
Deng and 
Zhang
[48]1
Deng et al. 
[49]2
blood
F: PDMS/DVB 
H: manual
R: the best reproducibility 
for extraction of PFBHA in 
aqueous solution than other 
fibers; aldehydes targeted 
OFD: 1 ml of PFBHA (17 mg/
mL), 25 ºC (10 min)
S: 1 ml in 8 ml vial
E: 60 ºC (8 min, 1100 rpm)
D: 270 ºC (2 min)
GC-QMS/EI
HP-5MS column  (30 m x 
0.25 mm x 0.25 μm)
0.001-0.006 
nM1 
SIM
0.0006 nM2
(hexanal)
0.005 nM2
(heptanal)
SIM
< 61 
< 8.52
0.991
0.9942
(hexanal)
0.9962
(heptanal)
41-450 
SIM
Fuchs et al. 
2010
[50]
breath
F: PDMS/DVB 
H: manual
R: aldehydes targeted
OFD: 50 mg of dry PFBHA, 
40 ºC (10 min) 
S: 10 ml in 20 ml vial
E: 60 ºC (8 min)
D: 270 ºC (1 min)
GC-QMS/EI
MDN-5S column (15 m x 
0.25 mm x 0.25 μm)
0.0013-
0.056 
nmol/L
(29 ppt – 1.3 
ppb) 
SIM
ns ns SIM 
García et al.
[51] breath
F: PDMS/DVB
H: manual, automatic
T: 75 μm PDMS/CAR,  PDMS 
(thickness ns), DVB/CAR/
PDMS
S: 5 L (Tedlar bag)
E: 25 ºC (60 min)
D: 175 ºC (5 min)
GC-ITMS/EI
VF-5MS column (60 m x 
0.25 mm x 0.25 μm) 
40 ng mL−1, 
(n-hexane)
FS
ns ns 35-280
Gaspar et al.
[52] breath
F: 100 μm PDMS 
H: manual
R: targeted non-polar 
hydrocarbons
T: DVB/CAR/PDMS
S: 5 L (Tedlar bag)
E: 25 ºC (30 min) 
D: 250 ºC (5 min)
GC-QMS/EI
GC-TOFMS/EI 
BPX5 column (30 m × 0.25 
mm x 1 μm)
0.04 - 8.0 
ppb (TOFMS)
 
FS
9-26 
(TOFMS) 
> 0.95 
(TOFMS)
40-450
 (QMS)
15-220
(TOFMS)
Guadagni 
et al.
[12]
urine
F: PDMS/DVB 
H: manual
R: aldehydes targeted
S: 3 ml in 10 ml vial (1 g of 
NaCl, 1 ng µL-1 IS solution)
E: 60 ºC (20 min, ultrasonic 
bath)
D: 200 ºC  (time ns)
GC-QMS/EI
CP-PoraBOND Q column 
(25 m x 0.25 mm x 3 μm)
1.1 pg/μl 
SIM 0.45-4.46 0.99
30-300 
SIM
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Hanai et al.
[53]1
[54]2
urine, 
cell culture 
medium
F: 2 cm DVB/CAR/PDMS 
H: automatic
T: CAR/PDMS (thickness ns), 
PDMS/DVB, PA
S: 200 µl in 2 ml vial
I: 45 ºC (10 min)
E: 45 ºC (50 min)
D: 240 ºC (10 min)
GC-TOFMS/EI Inert-Cap 
Pure-WAX T.L. column (60 
m + 2 m transfer line x 0.25 
mm x 0.5 μm) 
ns1
0.004-0.058 
µM2 
SIM
ns ns
1
> 0.992
40-500
SIM
Kischkel et 
al. [55] breath
F: 75 μm CAR/PDMS 
H: automatic
S: 10 ml in 20 ml glass vial 
I: 40 ºC (3 min, stirring)
E: 40 ºC (7 min) 
D: 290 ºC (1 min)
GC-ITMS/EI
CP PoraBond Q column (25 
m x 0.32 mm x 5 μm) 
0.023-1.305 
nmol/L SIM ns > 0.91
35-300
SIM 
Kwak et al.
[25]
cell culture 
medium F: 2 cm DVB/CAR/PDMS
S: 1 ml in 4 ml vial (750 mg of 
NaCl, pH 2, 3 or 10)
E: 37 ºC (30 min, stirring)
D: 230 ºC (time ns)
GC-QMS/EI
Stabilwax column
(30 m x 0.32 mm x 1 μm)
ns ns ns 41-400
Ligor et al. 
[56]
breath,
tissue
F: 75 μm CAR/PDMS 
H: manual 
S: 10 ml [breath]
S: 2.5 g in 20 ml glass vial 
[tissue]
I: 30 ºC (10 min)
E: 30 ºC (15 min) 
D: 200 ºC (1 min)
GC-QMS/EI
CP-PoraBOND Q column 
(25 m x 0.25 mm x 3 μm)
1.4-5.0 ppb
FS
0.6-0.9 ppb
SIM 
7-10 0.994-0.999
15-220 
SIM
Ligor et al.
[26]1
Bajtarevic 
et al.
[57]2
breath F: 75 μm CAR/PDMSH: automatic
S: 18 ml in 20 ml vial
E: 37 ºC (10 min)
D: 290 ºC (1 min)
GC-QMS/EI
CP-PoraBOND Q column 
(25 m x 0.32 mm x 5 μm)
0.05 - 15.00 
ppb1 
FS
0.7 - 17.2 
ppb2
FS
ns ns 35-200 
Matsumura 
et al. [58] urine
F: 2 cm DVB/CAR/PDMS
H: manual
S: 100 μl in 4 ml glass vial
E: 40 ºC (30 min)
D: 230 ºC (5 min)
GC-QMS/EI
Stabilwax column (30 m x 
0.32 mm x 1 μm)
ns ns ns 41-400 
Monteiro 
et al.
[22]
urine
F: PDMS/DVB 
H: automatic
T: DVB/CAR/PDMS, 100 μm 
PDMS, 7 μm PDMS, PA
S: 2 ml in 10 ml vial (0.59 g of 
NaCl, pH 2)
I: 68 ºC  (9 min)
E: 68 ºC (24 min, 250 rpm)
D: 250 ºC (4 min)
GC-ITMS/EI
VF-5 MS column (30 m x 
0.25 mm x 0.25 μm)
ns ns ns 40-400
Poli et al. 
[59] breath 
F: 75 μm CAR/PDMS 
H: manual 
S: 150 ml (using Bio-VOC® 
breath sampler)
E: 22 ºC (30 min) 
D: 280 ºC (5 min)
GC-QMS/EI 
Equity™-1 column
(30 m x 0.25 mm x 1 μm)
10 -12 M
FS 3.1–13.7 > 0.98 40-350 
Poli et al.
[60] breath
F: PDMS/DVB 
H: manual
OFD: 1 ml of PFBHA (17 mg/
mL), RT (10 min, stirring) 
S: 150 ml (using Bio-VOC® 
breath sampler)
E: RT (45 min)
D: 280 ºC (time ns)
GC-QMS/EI 
HP-5MS column (30 m × 
0.25 mm x 0.50 μm) 
0 x 10-12 
M
SIM 
7.2-15.1 0.97-0.99 SIM 
Pyo et al.
[61]
cell culture 
medium 
F: PDMS/DVB 
H: manual
S: cell culture medium 
(volume ns) in cell culture 
flask (size ns)
E: 40 min (250 ºC)
D: 200 ºC (5 min)
GC-QMS/EI
HP-5 column (30 m x 0.32 
mm x 0.25 μm)
0.04-0.4 ppb
SIM 1.02-8.23 > 0.99 SIM
Rudnicka 
et al.
[62]1
[63]2
breath F: 75 μm CAR/PDMSH: manual
S1: 10 ml in glass vial
S2: 1 L (Tedlar bag)
E1: 25 ºC (15 min)
E2: 25 ºC (10 min)
D: 200 ºC (2 min)
GC-TOFMS/EI
1
GC-QMS/EI 
2
CP-PoraBOND Q column 
(25 m × 0.25 mm x 3 μm)
0.31-0.75 
ppb1
FS
0.02-9.46 
ppb2 
FS
3.36-9.541
3-102
> 0.981
>0.9942
30-300 
Silva et al.
[27]
[28]
urine
F: 75 μm CAR/PDMS
H: manual
T: 100 μm PDMS, PDMS/
DVB, DVB/CAR/PDMS, 70 
μm CW/DVB, PA
S: 4 ml in 8 ml glass vial (0.8 
g of NaCl, pH 1-2)
E: 50 ºC (60 min)
D: 250 ºC (6 min)
GC-QMS/EI
BP-20 column (30 m × 0.25 
mm × 0.25 μm) 
ns ns ns 30-300 
Song et al.
[64] breath
F: 75 μm CAR/PDMS
H: manual
S: 4 L (Tedlar bag or glass 
bottle)
E: RT (30 min)
D: 250 ºC (time ns)
GC-QMS/EI 
RxiTM–5MS column (30 m 
× 0.25 mm × 0.25 μm)
ns < 6 0.996,0.988 35-350
Ulanowska 
et al
[65]
breath
F: 75 μm CAR/PDMS 
H: manual
T: 85 μm CAR/PDMS, 100 μm 
PDMS, PDMS/DVB, PDMS/
DVB (StableFlex), 70 μm CW/
DVB, DVB/CAR/PDMS, PA
S: 500 ml (transferred into 1L 
Tedlar bag)
E: 25 ºC (10 min) 
D: 200 ºC (time ns)
GC-QMS/EI
CPQ column (25m× 
0.25mm× 3  μm) 
ns ns ns 15-220 
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Adsorbent-type Coatings
In adsorbent-type coatings, solid porous polymer, porous carbon 
or silica is bonded to a liquid material coated on a fiber core. Sample 
molecules travel into pores of the adsorbent and may interact with 
its particles via hydrogen bonding, –  bonding or van der Waals 
interactions (Figure 3). Retention here is based on the size of the 
sample molecules and then the diameter of the pores and the amount 
of porosity. Pores are categorised into three types: macro (openings 
with > 500 Å), meso (openings 20-500 Å) and micro (2-20 Å). A pore 
retains a sample molecule which is half the size of the pore diameter 
[34]. There are three commercially available adsorbent-type stationary 
phases, which were used for the extraction of VOCs: CAR-PDMS, 
PDMS-DVB and DVB-CAR-PDMS (Table 1).
CAR-PDMS fibers were developed for the extraction of volatile and 
small analytical molecules. This is because CAR can be produced as a 
sieve with pores of variable sizes, with the micropores able to retain C3 
analytes. DVB polymer has a high amount of micropores and some 
macropores, so it is mainly used for the extraction of large volatile 
compounds and semi-volatile analytes. DVB-CAR-PDMS fiber coating 
was developed because CAR-PDMS fiber is not very efficient for the 
extraction of higher molecular weight compounds and PDMS-DVB is 
not very efficient for the desorption of lower molecular weight analytes. 
The ratio of the two solid materials (CAR and DVB) in the DVB-CAR-
PDMS fiber was determined by evaluating what thickness of each 
coating optimised the extraction of different sized hydrocarbons. The 
amounts of each compound detected with this fiber was between the 
amounts determined with the CAR-PDMS and the PDMS-DVB fibers, 
so it can be used for the analysis of a wide range of molecular weight 
compounds [34].
The analysis of volatiles as biomarkers of cancer was performed in 
most cases with the use of the 75 µm CAR-PDMS fiber regardless of the 
type of sample tested (Table 1). This fiber was initially developed for the 
extraction of volatile and small compounds so its use is justified [34]. 
Tests for the selection of the fiber with the best efficiency for collecting 
volatile analytes were conducted in some of the studies in Table 1. Such 
tests involved the introduction of the fiber into a mixture of known 
concentrations of VOCs commonly detected in human breath and 
representing different chemical groups [65]. In these tests 75 µm CAR-
PDMS was found most often to be the most efficient in terms of total 
peak area, number of detected compounds and reproducibility (Table 
1). PDMS and PA were the fibers with the least efficiency in these 
tests. The PA coating has a polar affinity and most VOCs in human 
breath are non-polar. The PDMS fiber is efficient for the collection 
of hydrocarbons, but perhaps not other VOCs. Interestingly, only 
Ulanowska et al. [65] compared two thicknesses of the CAR-PDMS 
type of coating (the 75 µm being slightly more efficient than 85 µm), 
which perhaps should be considered as a standard test that should be 
employed, as CAR-PDMS appears to be the most suitable fiber type for 
VOCs analysis. 
DVB-CAR-PDMS was the second most efficient fiber for VOC 
extraction from different types of matrix [22,27,28,51,65]. This fiber 
showed a very wide spectrum of detected compounds in the study of 
Barash et al. [41], where HS-SPME-GC-MS analysis identified 350-400 
CAR: Carboxen; D: Desorption; DVB: Divinylbenzene; E: Extraction; EI: Electron Ionization, F: SPME Fiber type Used; FID: Flame Ionization Detector, FS: Full Scan; 
GC: Gas - Chromatography; H: Holder type used; I: Incubation, IT: Ion Trap, LOD: Limit of Detection; M: Matrix; MS: Mass - Spectrometry; n/a: not applicable; ns: not 
specified; OFD: on-Fiber Derivatization; PA: Polyacrylate; PDMS: Polydimethylsiloxane; PEG: Carbowax-Polyethylene Glycol; PFBHA: O-(2,3,4,5,6-Pentafluorophenyl) 
Methylhydroxylamine Hydrochloride; RSD: Relative Standard Deviation; RT: Room Temperature; Q: Quadupole, R2: Coefficient of Determination; R: Reason for the SPME 
Fiber Selection; S: Sample; SIM: Selected Ion Monitoring; T: SPME fibers that were tested, TOF: Time-Of-Flight; 1 = parameter or result used/obtained in the study or with 
the use of the matrix with the superscript 1; 2 = Parameter or result used/obtained in the study or with the use of the matrix with the superscript 2.
Table 1: Demonstrates the analysed matrix, the type of fiber and holder used, the extraction conditions, the applied separation and the detection system, and the achieved 
methodvalidation parameters in the studies investigating potential biomarkers of cancer performed to date.
Wang et al.
[66]1
[23]2 
breath, 
blood1
blood2
F: 75 μm CAR/PDMS 
H: manual
S1: 10 ml [breath]
S1: 2 ml in 20 ml vial [blood]
S2: 2 ml, vial size ns
E: 40 ºC (40 min)
D: 200 ºC (2 min)
GC-QMS/EI
DB-5MS column
(30 m x 0.25 mm x 0.25 μm)
ns ns ns 35-200
Xue et al.
[67] blood
F: 75 μm CAR/PDMS 
H: manual
T: 100 μm PDMS, PDMS/
DVB, 65 μm CW/DVB, PA
S: 5 ml in 15 ml vial
E: 60 ºC (40 min, 1100 rpm)
D: 250 ºC (30 s)
GC-QMS/EI
HP-5MS column (30 m x 
0.25 mm x 0.25 μm)
ns 5.2 ns ns
Yu et al.
[68] breath
F: 100 μm PDMS 
H: manual
R: non-polar hydrocarbons 
targeted, thick phase more 
suitable for VOCs
S: 5 L (Tedlar bag) 
E: 26 ºC (20 min)
D: 280 ºC (10 min)
GC-FID
DB-1 column (30 m × 0.25 
mm × 0.25 μm)
1.2 x 10-2 – 
1.26 ng/ml
n/a
3.7-9.8 > 0.98 n/a
Yu et al.
[20]
breath,
cell culture 
medium
F: ns 
H: manual
S: 5 L (Tedlar bag) [breath]
S: cell culture medium 
(volume ns) in cell culture 
flask (size ns) 
E: 37 ºC (50 min) [breath]
E: RT (100 min) [cell culture 
medium]
D: ns
GC-MS (mass analyzer ns) 
column ns ns ns ns ns
Zhang et al.
[21]
cell culture 
medium
F: 75 μm CAR/PDMS
H: manual
S: 10 ml in 20 ml vial
I: 38 ºC (10 min)
E: 38 ºC (44 min, stirring)
D: 280 ºC (2 min)
GC-QMS/EI
Rx-5MS column (30 m × 
0.25 mm × 0.25 μm)
ns ns ns 42-400
Zimmermann 
et al
[24]
cell culture 
medium
F: CAR/DVB 
H: manual
R: expected alcohols, esters 
and ketones
S: cell culture medium 
(volume ns) in glass flask 
(volume ns)
E: 37 ºC (40 min)
D: 200 ºC (20 s)
GC-QMS/EI
SB-11 column (60 m × 0.32 
mm × 0.2 μm)
ns ns ns ns
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different VOCs either produced or consumed by at least one of the 
investigated seven lung cancer cell lines. However, this group did not 
try any other fiber coating. Interestingly, in the only test comparing 
75 µm CAR/PDMS with 2 cm DVB/CAR/PDMS fiber, the latter had 
better efficiency [53,54].
The PDMS-DVB fiber was selected in studies targeting aldehydes 
with on-fiber derivatization with O-(2,3,4,5,6-pentafluorophenyl) 
methylhydroxylamine hydrochloride (PFBHA) [48-50,60]. This fiber 
was proven to be the most efficient in loading PFBHA, when different 
fibers (CAR-PDMS among them) were tested in terms of selectivity 
(mass loading of PFBHA and peak tailing), reproducibility, and ability 
to retain the largest amounts of PFBHA [69]. PDMS-DVB fiber has 
also shown very good sensitivity in a study targeting aldehydes without 
derivatization [12,22]. The fiber also showed better efficiency than 
CAR-PDMS for the collection of VOCs in tests where skin tissue 
was studied [39]. In the study of García et al. [51], both PDMS-DVB 
and DVB/CAR/PDMS showed a higher number of detected VOCs 
than 75 µm CAR/PDMS. They had very similar performance with 
25 VOCs detected with the use of the former and 24 with the use of 
the latter. Interestingly, this study shows that the different fiber types 
can be used complementarily as they detect different compounds (eg. 
ethyl acetate and estirene being detected solely by PDMS-DVB, and 
bromodichloromethane and isooctane only by DVB/CAR/PDMS).
100 µm PDMS was the fiber of choice in studies where non-polar 
hydrocarbons only were targeted and has shown relatively low limits of 
detection (LODs) (Table 1). In addition, it was more efficient for these 
analytes when tested along with 1 cm DVB-CAR-PDMS [52].
Extraction Time and Temperature
Extraction time is usually the most time-limiting factor in SPME, 
and is therefore one of the main parameters to optimise. It might be 
shortened by efficient agitation of aqueous solutions and/or elevation 
of temperature. However, although higher temperatures result in the 
more efficient release of compounds from the matrix, an increase in 
temperature simultaneously causes loss of sensitivity as distribution 
constants decrease i.e. equilibrium is reached faster but the amount 
of analyte extracted is smaller at this equilibrium [34]. Therefore, 
the selection of the time of extraction is a compromise between the 
sensitivity, length and repeatability of the method. Agitation reduces 
the time it takes for equilibrium to be reached, and improves sensitivity 
in pre-equilibrium extraction, as it enhances the mass transport 
between the sample and the stationary phase of a fiber.
For the in vitro and in vivo studies of potential cancer biomarkers 
various sample times were employed ranging from 15 hr to 10 min 
(Table 1). They depend on the temperature, sample volume and matrix 
conditions employed during extraction. 
Matrix Conditions
Better sensitivity of the SPME method may be achieved by 
optimisation of the matrix conditions which include sample volume 
(in the case of HS extraction), temperature, pH, ionic strength, sample 
agitation and the addition of an organic modifier. Salt addition (increase 
of ionic strength) and pH adjustment are common techniques for the 
enhancement of the extraction efficiency of organic analytes from 
aqueous solutions [34].
Sample volume
Phase ratio is the proportion of gaseous volume to the sample 
volume in the vial. The lower the values of phase ratio, the better the 
sensitivity of the HS method. Therefore, the HS volume should be as 
small as possible in order to achieve higher sensitivity, as equilibration 
time is reduced and the mass of compound extracted by fiber increases 
thereby improving detection limits [70]. The larger the HS volume, the 
more of the analysed compound goes into the HS, and the less goes 
onto the SPME fiber and remains in the liquid phase [71]. 
Salt addition
The ionic strength of the sample is modified by the addition of 
salt and it may influence the extraction in two ways: modifying the 
properties of the phase boundary or a “salting-out” effect. The latter 
refers to the process of decreasing the solubility of hydrophobic analytes 
in the aqueous phase, and is more often observed. The sensitivity of 
HS analytical methods is widely enhanced by the “salting-out” effect 
[71]. The process improves sensitivity through the formation of 
hydration spheres by water molecules with salt ions. This effect drives 
the additional sample molecules into the HS due to a reduction in the 
concentration of water molecules available for dissolving analysed 
compounds. However with a higher concentration of salts an opposite 
process may occur. Electrostatic interactions of analyte molecules with 
the ionic salt molecules in the solution may reduce their movement 
into the HS [32]. In general, salt addition increases the extraction of 
polar compounds. However, it has no significant effect on non-polar 
compounds.
Salt was added to the urine samples in the studies of Silva et al. 
[27,28], however they did not test the efficiency of extraction with 
higher or lower amounts of salt. The optimum amount of salt found 
with the use of CCD was 0.59 g per 2 ml of urine [22]. The “salting 
Polymer coating and thickness Recommended application Mechanism MW Polarity
100 µm PDMS Volatiles Absorbent 60-275 Non-polar
30 µm PDMS Non-polar semi-volatiles Absorbent 80-500 Non-polar
7 µm PDMS Non-polar high molecular weight compounds Absorbent 125-600 Non-polar
60 µm PEG Alcohols and polar compounds Absorbent 40-275 Polar
85 µm PA Polar semi-volatiles Absorbent 80-300 Polar
75 µm/85 µm CAR/PDMS Gases and low molecular weight compounds Adsorbent 30-225 Bipolar
65 µm PDMS/DVB Volatiles, amines and nitro-aromatic compounds Adsorbent 50-300 Bipolar
60 µm PDMS/DVB Amines, nitroaromatic and polar compounds (HPLC use only) Adsorbent 50-300 Bipolar
50/30 µm DVB/CAR/PDMS on a StableFlex fiber Flavour compounds: volatiles and semi-volatiles, C3-C20 Adsorbent 40-275 Bipolar
50/30 µm DVB/CAR/PDMS on a 2 cm StableFlex fiber Trace compound analysis Adsorbent 40-275 Bipolar
 CAR: Carboxen; PDMS: Polydimethylsiloxane; DVB: Divinylbenzene; HPLC: High Performance Liquid Chromatography; PA: Polyacrylate; PEG: Carbowax-Polyethylene 
Glycol [19].
Table 2. Summary of commercially available SPME fibers.
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out” effect was tested in another study, where different amounts of 
sodium chloride were added to urine samples and then signal to noise 
ratio values of all the analytes were examined. Salt addition improved 
the extraction recovery and sensitivity of the method [12]. The blood 
matrix has not been treated with salts as this could result in clot 
formation unless the blood sample is deproteinisated [34]. 
pH adjustment
pH adjustment may improve method sensitivity through 
conversion of the ion species into neutral forms. Only the neutral/
undissocated species of compounds are adsorbed/absorbed from the 
HS by the SPME fiber. Low pH values will benefit the extraction of 
acidic analytes, and high values will increase the extraction efficiency 
of basic compounds. Kwak et al. [25] reported that some organic acids 
were major VOCs detected at low pH value and were barely visible in 
chromatogram obtained in neutral conditions. On the other hand, the 
intensities of many other compounds decreased with a reduction of pH. 
Acidic pH (pH 2) was found to be the optimum, both in terms of the 
total number of the detected compounds and the total chromatographic 
peak area obtained, for the extraction of VOCs from the urine samples 
by Monteiro et al. [22]. Silva et al. [27,28] also adjusted urine samples 
to 1-2 pH. The group did not test, however, neutral or high pH values 
to establish the optimum pH of extraction.
Desorption
Desorption times used in VOC studies of cancer vary greatly from 
20 s (at 200°C) to 10 min (at 240°C). In general, an increase of the 
injector temperature reduces desorption time. Maximum fiber coating 
durability may be achieved by minimizing the temperature and time of 
desorpton. On the other hand both parameters must be compromised 
to prevent an analyte carry-over. In general, when the temperature of 
the injector port is 200°C, desorption time is approximately 1 second 
for a 100 µm coating for low molecular mass compounds such as 
VOCs. Desorption is successfully carried out by the generation of a 
high linear flow rate, which ensures that the desorpted compound is 
removed immediately from the stationary phase of a fiber [34]. As there 
is no solvent use with SPME, the desorption is usually performed in 
splitess mode aiding sensitivity [19]. 
The desorption time has been optimised in one study in Table 2 
by determination of the sum of peak areas yielded under different 
desorption times (10, 20, 30, 40, 60, 90 and 120 s at 250ºC) [67]. 
Holding the SPME fiber in the injector port for longer than 30 s did not 
result in further improvement of the detector’s response. Therefore 30 
s has been chosen for all subsequent experiments.
Calibration
SPME as a non-exhaustive method needs careful selection of 
calibration for quantitative analysis. Quantification of analytes in 
SPME is based on the principle that the amount of compound extracted 
onto the stationary phase is linearly proportional to the compound 
concentration in the sample. There are several calibration methods 
available for SPME [72]. Studies of VOCs as cancer biomarkers where 
quantification has been performed used mainly the external standards 
method of calibration (Table 1). This is acceptable as long as blank 
sample matrices are available. These blank samples are breath, blood 
and urine from healthy patients and pure culture medium for in vitro 
studies (medium incubated for the same amount of time as the in vitro 
grown cells). Alternatively a method of internal standard addition may be 
used. Here, however, one must be sure that a chosen internal standard is 
affected by matrix in the same way as compounds of interest [73].
In some sample types, such as urine or cell culture medium, matrix 
effects are expected as the composition of the matrix is not entirely 
known. Here a standard addition method of calibration should be used. 
For example Pyo et al. [61] investigated VOCs present in the HS of the 
lung cancer cells grown in vitro. For method validation the researchers 
prepared the mixture of standard solution in methanol (external 
standards method of calibration). Here the slope of the calibration 
graph could potentially differ from the one obtained with the use of the 
standard addition method (performed in the cell culture medium as a 
matrix). This is because the partition coefficients of analytes depend 
on the composition of the matrix and polarity of the compounds [73]. 
They are different for methanol and cell culture medium. In addition, 
methanol could potentially compete with the analytes for the places of 
absorption and/ or adsorption on the SPME fiber. 
Method validation
Once the SPME parameters are optimised, the method should be 
tested for a particular application. The tests using optimal extraction 
conditions should include evaluation of the limits of detection (LOD) 
and quantitation (LOQ), precision and accuracy of the method, method 
selectivity and linear dynamic range.
There are different definitions of the LOD in literature [12,74,75]. 
In the studies, where the LOD level was specified, it was calculated on 
the basis of ion signal to noise ratio = 3 (Table 1). The SPME methods 
used by researchers in the studies summarised in Table 1 differ in their 
sensitivity, accuracy and precision. These variations are probably the 
results of differences in the fiber used, the analytical instrument used 
for detection and separation of VOCs, and the choice of equilibrium or 
pre-equilibrium times of extraction. 
According to the Food and Drug Administration [75], for the 
bioanalytical methods the determined precision should not exceed 15% 
of the coefficient of variation (also known as relative standard deviation, 
RSD). The coefficient of determination (denoted as R2) indicates 
how well the data fits a linearity curve. The R2 value for a calibration 
curve should be ≥0.997 for the linearity of the analytical method to be 
achieved [76]. The RSD values in most of the studies presented in Table 
1 were < 10% indicating a very good level of precision for these SPME 
methods. SPME experiments that included derivatization were shown 
to have higher RSD values, probably due to the additional preparation 
step. The R2 values were > 0.997 for most of the VOCs in these studies 
showing very good accuracy of the data models.
SPME versus other extraction techniques 
The second main technique along with SPME for the collection of 
VOCs from exhaled breath or the HS of biological specimens in studies 
of potential cancer biomarkers is PT (called also dynamic headspace). 
In comparison to PT, SPME involves fewer steps. PT consists of 
extraction of the analytes onto the sorbent tube, primary desorption, 
cold focusing, and secondary desorption. SPME is more simple in 
use, as it involves firstly sorption of the VOCs onto the fiber, and 
then desorption. SPME’s ease of use makes possible the development 
of normalised methods and standardisation [77]. Limits of detection 
obtained in the studies analysing volatiles as potential cancer biomarkers 
showed similar levels as sorbent tubes (high-medium ppt range in full 
scan mode) [62,63,78]. However, although new SPME coatings are 
under development, there are 10 coating types (compatible with GC) 
commercially available at the moment. In contrast, there are over 
20 different sorbent types commercially available for the sorbent 
tubes. In addition, sorbent tubes may be packed with up to four 
different sorbents, making it very attractive due to its versatility. 
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Other drawbacks of SPME include: ease of the breakage of the fiber, 
stripping of the coatings, and relatively expensive cost of a fiber 
assembly. Nevertheless, SPME is an attractive alternative to PT 
due to its lower cost in hardware (no need for a special desorption 
unit to be installed, nor is there any requirement for the pump or 
vacuum devices that are required for PT). Sorbent tubes are also 
relatively expensive. In addition, some sorbents have high affinity 
to water which may cause column degradation [79].
Other extraction techniques used in the analysis of VOCs in 
cancer studies include the needle trap device (NTD) and single drop 
microextraction (SDME) [80,81]. The NTD contains a sorbent trap 
inside a needle. The analytes present in a liquid or a gas sample can be 
actively drawn into and out of the needle using a syringe or a pump, or 
passively be introduced via the diffusion process. This technique (as in 
the case of PT) is exhaustive and can achieve similar limits of detection 
to SPME (high-medium ppt range in SIM mode) [56,80]. SDME, in 
which a small drop of solvent (around 2 µl) is suspended from the tip 
of the needle where the compounds are extracted from the headspace, 
offers relatively low costs, simplicity and elimination of carry over. 
With the use of in-drop derivatization, SDME offers limits of detection 
in low ppb range (in SIM mode) [82].
Other commercially available microextraction techniques that 
could be potentially used in the analysis of VOCs in cancer studies 
include Stir bar sorptive extraction (SBSE) and Monolithic material 
sorptive extraction (MMSE, also called MonoTraps). Both techniques, 
as in the case of SPME, rely on partitioning of analytes between 
a stationary phase and a sample matrix. In SBSE the analytes are 
extracted by a stir bar, coated with a stationary phase, in the aqueous 
solution. However, a stir bar has been previously used also for the 
HS extraction of volatiles [83]. SBSE technology requires relatively 
expensive instrumentation (a special thermal desorption unit) and the 
bars are available with three types of coatings: PDMS, PA and ethylene 
glycol (EG)-silicone. The extraction of VOCs with the use of MMSE 
can be performed either in a HS or a floating mode. MonoTraps are 
available in two variants: traps for thermal desorption (which requires 
a thermal desorption unit) or traps for liquid extraction (which makes 
this variant of MonoTraps relatively cheap). MMSE is also limited in 
the types of the sorptive material, as there are two types available: one 
made of silica and the other made of silica with activated carbon. In 
environmental analysis the use of SBSE for the collection of VOCs 
from water has yielded LOD in the low ppb range (in full scan mode) 
[84]. MMSE has shown similar limits of detection to HS-SPME in the 
study analysing VOCs in wine (low ppm in full scan mode) [85]. But 
both SBSE and MMSE could show different LODs when applied for the 
analysis of VOCs in biological specimens. 
Conclusions
The VOCs profile of a biological sample potentially can provide 
useful information about human health. The composition of the 
compounds will vary depending on the disease. VOCs may therefore 
serve as potential biomarkers in cancer detection and screening 
contributing to its early detection and treatment monitoring of various 
diseases, cancer among them. SPME is one of the main extraction 
techniques used in the studies analysing volatiles as potential cancer 
biomarkers. When the extraction of VOCs as potential biomarkers 
of cancer is an untargeted analysis and, therefore, all the volatile 
compounds in the sample are of potential interest, fiber selection 
tests should be routine for a given type of cancer, cell line, matrix 
used etc. The optimised parameters of extraction and desorption vary 
greatly between the studies analysing VOCs-associated with cancer. 
These parameters depend on the type of the sample, sample size, and 
analytical technique used. Researchers who performed the tests for the 
most efficient SPME coating for VOC extraction from different types 
of matrix in cancer studies, most frequently selected 75 µm CAR-
PDMS as the fiber used for further analysis. Use of an autosampler aids 
reproducibility and quality of analysis. On the other hand, the use of 
a manual device does not restrict a sample size. SPME is an attractive 
extraction technique for collection of VOCs from different samples in 
the studies of cancer as it eliminates the use of solvents, is relatively 
cheap and simple in use and its sensitivity may be further improved 
by the development of the new fiber coatings. However, there are 
competitive extraction techniques available, some of them offering 
similar limits of detection at a lower price.
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